| 9670208 |
Serine/threonine kinase inhibitors |
James F. Blake, Adam Cook, John Gaudino, Indrani W. Gunawardana, Erik James Hicken +11 more |
2017-06-06 |
| 9592235 |
Aminoquinazoline and pyridopyrimidine derivatives |
Terry Crawford, Seth F. Harris, Steven R. Magnuson, Chudi Ndubaku, Lan Wang |
2017-03-14 |
| 9586956 |
Isoquinoline and naphthyridine derivatives |
Terry Crawford, Steven R. Magnuson, Chudi Ndubaku, Lan Wang |
2017-03-07 |
| 9580411 |
Substituted sulfonamide compounds |
Christine E. Brotherton-Pleiss, Shaoqing Chen, Zhi Chen, Shawn David Erickson, Anthony A. Estrada +8 more |
2017-02-28 |
| 9440976 |
1,7-diazacarbazoles and methods of use |
Hazel Joan Dyke, Lewis Gazzard, Karen Williams, Samuel Kintz, Joy Drobnick +4 more |
2016-09-13 |
| 9388171 |
Serine/threonine kinase inhibitors |
Jim Blake, Mark Joseph Chicarelli, John Gaudino, Lewis Gazzard, Sam Kintz +4 more |
2016-07-12 |
| 9382241 |
Aminoquinazoline and pyridopyrimidine derivatives |
Terry Crawford, Seth F. Harris, Steven R. Magnuson, Chudi Ndubaku, Lan Wang |
2016-07-05 |
| 9382257 |
Substituted pyrrolo[2,3-b]pyrazines as serine/threonine kinase inhibitors |
Daniel J. Burdick, Shumei Wang, Weiru Wang |
2016-07-05 |
| 9259470 |
Serine/threonine kinase inhibitors |
James F. Blake, Mark Joseph Chicarelli, Rustam Ferdinand Garrey, John Gaudino, Jonas Grina +6 more |
2016-02-16 |
| 9260450 |
Therapeutic pyrazolyl thienopyridines |
Stephen Douglas Barrett, James Bernard Kramer, Mark Laurence Boys |
2016-02-16 |
| 9216980 |
Methods of use of diazacarbazoles for treating cancer |
Hazel Joan Dyke, Charles Ellwood, Emanuela Gancia, Lewis Gazzard, Simon Charles Goodacre +4 more |
2015-12-22 |
| 9212173 |
Pyrazole aminopyrimidine derivatives as LRRK2 modulators |
Charles Baker-Glenn, Daniel J. Burdick, Bryan Chan, Mark Stuart Chambers, Anthony A. Estrada +1 more |
2015-12-15 |
| 9187462 |
Substituted quinazolines as serine/threonine kinase inhibitors |
James F. Blake, Mark Joseph Chicarelli, Jason Demeese, Rustam Ferdinand Garrey, John Gaudino +8 more |
2015-11-17 |
| 9145402 |
Aminopyrimidine derivatives as LRRK2 modulators |
Charles Baker-Glenn, Mark Stuart Chambers, Bryan Chan, Anthony A. Estrada, Daniel Shore +1 more |
2015-09-29 |
| 9133187 |
Serine/threonine kinase inhibitors |
James F. Blake, Mark Joseph Chicarelli, Jason Demeese, Rustam Ferdinand Garrey, John Gaudino +11 more |
2015-09-15 |
| 9090625 |
Therapeutic pyrazolyl thienopyridines |
Stephen Douglas Barrett, James Bernard Kramer, Mark Laurence Boys |
2015-07-28 |
| 8815882 |
Pyrazole aminopyrimidine derivatives as LRRK2 modulators |
Charles Baker-Glenn, Daniel J. Burdick, Mark Stuart Chambers, Bryan Chan, Anthony A. Estrada +1 more |
2014-08-26 |
| 8809331 |
Aminopyrimidine derivatives as LRRK2 modulators |
Charles Baker-Glenn, Daniel J. Burdick, Mark Stuart Chambers, Bryan Chan, Anthony A. Estrada +5 more |
2014-08-19 |
| 8802674 |
Aminopyrimidine derivatives as LRRK2 modulators |
Charles Baker-Glenn, Daniel J. Burdick, Mark Stuart Chambers, Bryan Chan, Anthony A. Estrada +5 more |
2014-08-12 |
| 8697715 |
Serine/threonine kinase inhibitors |
James F. Blake, Mark Joseph Chicarelli, Rustam Ferdinand Garrey, John Gaudino, Jonas Grina +6 more |
2014-04-15 |
| 8569281 |
Compounds and their administration for treating a neurodegenerative disease as well as a method for identifying a compound capable of inhibiting a kinase, such as LRRK |
Bryan Chan, Anthony A. Estrada, Daniel Shore, Zachary K. Sweeney, Edward Giles Mciver |
2013-10-29 |
| 8501765 |
Diazacarbazoles and methods of use |
Hazel Joan Dyke, Charles Ellwood, Emanuela Gancia, Lewis Gazzard, Simon Charles Goodacre +4 more |
2013-08-06 |
| 8455512 |
Therapeutic pyrazolyl thienopyridines |
Stephen Douglas Barrett, James Bernard Kramer, Mark Laurence Boys |
2013-06-04 |
| 8354420 |
Aminopyrimidine derivatives as LRRK2 inhibitors |
Charles Baker-Glenn, Daniel J. Burdick, Mark Stuart Chambers, Bryan Chan, Anthony A. Estrada +5 more |
2013-01-15 |
| 7964612 |
Therapeutic pyrazolyl thienopyridines |
Stephen Douglas Barrett, James Bernard Kramer, Mark Laurence Boys |
2011-06-21 |
